Research article · 10 Jun 2025
Short communicationPublished 24 Aug 2023
RNA editing and the epitranscriptome in heart failure
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The arising utilization of immunotherapies in disease treatment builds the gamble of immunotherapy-related cardio toxicity. Rather than regular chemotherapy, these original treatments have extended the structures and introductions of cardiovascular harm to a wide range from asymptomatic changes to fulminant short-and long haul difficulties concerning cardiomyopathy, arrhythmia, and vascular illness. In disease patients and, especially, malignant growth patients going through (resistant) treatment, cardio-oncological observing is a mind boggling exchange between pretherapeutic risk evaluation, recognizable proof of looming cardio toxicity, and post-remedial observation. For these reasons, the cardio-oncologist can return to a wide range of atomic cardio logical demonstrative workup.
Keywords
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Current Trends in Cardiology.
Mini review · 27 Jan 2025
Wearable Heart Monitors: Transforming Cardiovascular Health Through Technology
Mini review · 27 Jan 2025
The Emerging Field of Cardio-Oncology: Understanding the Intersection of Heart Health and Cancer Treatment
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCurrent Trends in Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Jacek Kubica”

